SCHEMBL1614723

SCHEMBL1614723

CCOC(=O)c1c(C)nn2c(=O)cc(-c3ccc(OC)cc3)[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.50
GAA P10253 2/20 0.50
PDE4D Q08499 1/20 0.50
PLAT P00750 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 2/20 0.46
MAPK10 P53779 1/20 0.46
MAPT P10636 6/20 0.45
THRB P10828 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
GRM6 O15303 1/20 0.45
ALDH1A1 P00352 6/20 0.44
KMT2A Q03164 4/20 0.44
KDM4E B2RXH2 3/20 0.44
KCNQ2 O43526 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 2/20 0.42
APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23700005 0.89 PLAT (0.45) GAAPDE4DPLATSMN1; SMN2HTT
SCHEMBL1613376 0.88 PLAT (0.49) POLBGAAPDE4DPLATSMN1; SMN2
SCHEMBL1286573 0.87 PLAT (0.51) POLBGAAPDE4DPLATSMN1; SMN2
SCHEMBL1614704 0.84 PLAT (0.46) POLBGAAPLATSMN1; SMN2HTT
SCHEMBL13516216 0.79 KDM4E (0.43) GAASMN1; SMN2HTTMAPTTHRB
SCHEMBL1614348 0.79 PLAT (0.56) POLBPDE4DPLATMAPTL3MBTL1
SCHEMBL23198906 0.79 PTGS2 (0.42) GAAPLATSMN1; SMN2HTTMAPT
SCHEMBL15659837 0.79 PLAT (0.42) GAAPLATSMN1; SMN2MAPTRAB9A
SCHEMBL1614394 0.78 PDE4B (0.54) PDE4DPLATMAPTRAB9AALDH1A1
SCHEMBL1614494 0.77 PLAT (0.48) PDE4DPLATALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 POLB 2845/4885GAA 1511/4885PDE4D 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.